Awareness and Attitude of Medicine Consumers towards ADR Reporting: A Questionnaire based study of Rural Chhattisgarh-Reference-Cited by-同舟云学术

Awareness and Attitude of Medicine Consumers towards ADR Reporting: A Questionnaire based study of Rural Chhattisgarh

Published:2024-02-29 Issue: Volume: Page:58-61
ISSN:2321-5836
Container-title:Research Journal of Pharmacology and Pharmacodynamics
language:en
Short-container-title:RJPPD

Author:

Ahmed Tabish¹,Kaikade S.B.²

Affiliation:

1. Associate Professor, Department of Pharmacology, BRLSABVM GMC Rajnandgaon, Chhattisgarh.

2. Professor, Department of Pharmacology, Dr. N Y Tasgaonkar Institute of Medical Sciences, Karjat, Maharashtra.

Abstract

The National Pharmacovigilance Programme is coordinated by the Indian Pharmacopoeia Commission at Ghaziabad. The Pharmacovigilance Programme of India (PvPI) is now in full swing. We have a network of some 90 adverse drug reaction (ADR) Monitoring Centres (AMCs) across the country. The programme provides financial, logistic and technical support to the AMCs. Initially, only health professionals could report the ADR. Recently PvPI has included all people who consume medicine and not just health professionals, to report ADR. A toll free consumer helpline (1800 180 3024 operational on weekdays during office hours) and a dedicated email address (PvPI.compat@gmail.com) have been launched to encourage people to report ADRs. Aim and objectives: To study awareness and attitude of medicine consumers towards ADR reporting Materials and methods: This is a questionnaire based study where consumers will be given the questionnaire regarding ADRs and their reporting. Study plan: Time duration - 3months. Discussion: It is important to spread awareness and importance about ADR reporting amongst the general population.

Publisher

A and V Publications

Reference18 articles.

1. Preeti S, Manju A, Rajesh Hr et al. Adverse drug reactions at adverse drug reaction monitoring center in Raipur:Analysis of spontaneous reports for 1 year. Indian Journal of Pharmacology. 2017.

2. Shepherd G, Mohorn P, Yacoub K, May DW. Adverse drug reaction deaths reported in United States vital statistics, 1999-2006. Ann Pharmacother. 2012; 46(2): 169-75

3. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions:a systematic review of prospective observational studies. Ann Pharmacother. 2008; 42(7): 1017-25

4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients:a meta-analysis of prospective studies. JAMA. 1998; 279(15): 1200-5

5. World Health Organization. Medicines safety, 2017.Available at http://www.who.int/medicines/regulation/medicines-safety/en/(Accessed on 1 October 2017).